We propose the extension of existing knowledge on the functional and biochemical characterization of neurologic disease through the use of new radiotracer techniques involving positron emission tomography. We will continue the development of new radiotracer techniques for the study of important biochemical hypotheses of the pathophysiologic mechanisms underlying degenerative brain diseases. Our focus in this area is on the introduction of noninvasive methods for assessment of mitochondrial oxidative capacity, permitting the future testing of hypotheses on the role of oxidative toxicity in the progression of neuronal loss in disorders such as Parkinson's and Huntington's diseases and amyotrophic lateral sclerosis. Clinical aspects of the program will focus on the neuropharmacologic characterization of neurodegenerative movement disorders, including olivopontocerebellar atrophy, multiple system atrophy, Alzheimer's disease with extrapyramidal symptoms, Parkinson's disease, essential tremor, Huntington's disease, Tourette's syndrome, and dystonia. The proposed studies will elucidate features of these disorders which will advance understanding of the neuronal elements affected in symptomatic patients, as well as characterization of the relationships between the stage and progression of disease and the severity and distribution of altered neurochemical markers. We will focus attention on new methods for quantitative evaluation of synaptic binding sites for acetylcholine, dopamine and benzodiazepines, and on the novel determination of presynaptic monoaminergic and cholinergic vesicles as an indicator of presynaptic integrity. Results of the proposed studies will not only permit better taxonomic distinctions among the extrapyramidal movement disorders, but may yield important information for the introduction of new therapeutic strategies on the basis of rational pharmacologic design. These neurochemical data will permit development of better symptomatic therapies, as well as the evaluation of potential disease-modifying (neuroprotective) approaches.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS015655-20
Application #
2891579
Study Section
Neurological Disorders Program Project Review A Committee (NSPA)
Program Officer
Sheehy, Paul A
Project Start
1979-12-01
Project End
2001-06-30
Budget Start
1999-07-01
Budget End
2001-06-30
Support Year
20
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Albin, Roger L; Fisher-Hubbard, Amanda; Shanmugasundaram, Krithika et al. (2015) Post-Mortem evaluation of amyloid-dopamine terminal positron emission tomography dementia classifications. Ann Neurol 78:824-30
Soileau, Michael J; Persad, Carol; Taylor, Jennifer et al. (2014) Caregiver burden in patients with Parkinson disease undergoing deep brain stimulation: an exploratory analysis. J Parkinsons Dis 4:517-21
Shao, Xia; Fawaz, Maria V; Jang, Keunsam et al. (2014) Ethanolic carbon-11 chemistry: the introduction of green radiochemistry. Appl Radiat Isot 89:125-9
Younes, Laurent; Ratnanather, J Tilak; Brown, Timothy et al. (2014) Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis. Hum Brain Mapp 35:792-809
Kilbourn, Michael R (2013) PET radioligands for the vesicular transporters for monoamines and acetylcholine. J Labelled Comp Radiopharm 56:167-71
Shao, Xia; Schnau, Paul L; Fawaz, Maria V et al. (2013) Enhanced radiosyntheses of [¹¹C]raclopride and [¹¹C]DASB using ethanolic loop chemistry. Nucl Med Biol 40:109-16
Bohnen, Nicolaas I; Müller, Martijn L T M (2013) In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease. J Neural Transm (Vienna) 120:571-6
Meisler, Miriam H; Grant, Adrienne E; Jones, Julie M et al. (2013) C9ORF72 expansion in a family with bipolar disorder. Bipolar Disord 15:326-32
Shao, Xia; Hoareau, Raphaël; Hockley, Brian G et al. (2011) Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN). J Labelled Comp Radiopharm 54:292-307
Chen-Plotkin, Alice S; Martinez-Lage, Maria; Sleiman, Patrick M A et al. (2011) Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol 68:488-97

Showing the most recent 10 out of 27 publications